Osteoprotegerin,whichisamemberofthetumornecrosisfactorreceptorsuperfamilyandisinvolvedintheregulationofbonemetabolism.OPGanditsligand(OPGL)arecytokinesregulatingosteoclasto-genesis.OPGLbindstoreceptorsonthesurfaceofpreosteoclastsandstimulatestheirdifferentiationintoactiveosteoclasts.Thisleadstoosteoresorption.OPGinhibitsthisosteoclasto-genesis(OPGissecretedbyosteoblasts,andbindstoOPGL,thusinhibitingmaturationofosteoclastsandosteoresorption).ThedegreeandactivityofosteoresorptiondependmainlyonthebalancebetweenOPGanditsligand(OPGL);factorsincreasingOPGLexpressionmostlyreduceOPGexpressionandviceversa.
Reference:
1.Effectsofhypolipemicdrugsontheosteoprotegerin-sRANKLsysteminpatientswithcoronaryarterydisease. ThrombHaemost2007May;97(5):868-70
2.Plasmaosteoprotegerinlevelsinthegeneralpopulation:relationtoindicesofleftventricularstructureandfunction. Hypertension2007Jun;49(6):1392-8
3.Thesex-specificassociationofserumosteoprotegerinandreceptoractivatorofnuclearfactorkappaBlegendwithbonemineraldensityinolderadults:theRanchoBernardostudy. EurJEndocrinol2007May;156(5):555-62
4.Thyroidhormonedeficiencyandpostmenopausalstatusindependentlyincreaseserumosteoprotegerinconcentrationsinwomen. EurJEndocrinol2007May;156(5):539-45
5.Abnormalboneremodelingprocessisduetoanimbalanceinthereceptoractivatorofnuclearfactor-kappaBligand(RANKL)/osteoprotegerin(OPG)axisinpatientswithsolidtumorsmetastatictotheskeleton.
ActaOncol2007;46(2):221-9
6.Inhibitionoftoothmovementbyosteoprotegerinvs.pamidronateunderconditionsofconstantorthodonticforce. EurJOralSci2007Apr;115(2):131-6
Neuromics公司提供一系列高品质新蛋白的抗体、神经干细胞及培养基、神经干细胞扩增及分化试剂盒、干细胞抗体、神经和前体细胞流式分型试剂、细胞凋亡研究试剂、荧光激活细胞分拣法试剂盒、细胞内部试剂盒、转染试剂、ELISA 缓冲稀释液与IHC-WB-ELISA 补充物等试剂。
Neuromics因为是由一批顶尖的学术和商业实验室挑选,试验和创新他们的 试剂来满足顾客的需要而使自己的表现尤为突出。Neuromics从 以上过程中获得的经验使得顾客****的实际应用和试剂独特的性能能够得以相容。它精通于提供试剂和为神经科学研究机构提供产品和服务。